Please login to the form below

Not currently logged in
Email:
Password:

Valeant completes AB Sanitas purchase

Canada-based Valeant Pharmaceuticals International has completed the acquisition of AB Sanitas in a deal worth €314m

Canada-based Valeant Pharmaceuticals International has completed the acquisition of AB Sanitas in a deal worth €314m.

Announced in May 2011, the deal will see Valeant take full control of the Lithuania-based speciality pharmaceutical firm, gaining 390 generic products in nine Central and Eastern European countries.

Valeant has made several acquisitions in 2011, including the February purchase of privately held firm PharmaSwiss for €350m. This was followed in July by the acquisition of Sanofi's Dermik dermatology unit for $425m.

At the end of July 2011, Valeant was rumoured to be considering making a bid for Sweden-based Meda, and in August 2011, The Wall Street Journal reported Valeant was to purchase dermatological specialists Medicis.

22nd August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics